相关实验视频

Updated: Jul 28, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

重新思考抗原来源:基于整个瘤细胞/组织溶解物或整个瘤细胞的癌症疫苗

Lu Diao^1,2,3, Mi Liu^1,2,3

¹Department of Pharmaceutics, College of Pharmaceutical Sciences, Soochow University, 199 of Ren ai Road, Suzhou, Jiangsu, 215123, P. R. China.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

|May 31, 2023

概括

使用全瘤抗原的癌症疫苗,如细胞溶解物,为预定义的抗原疫苗提供了一个有希望的替代方案. 这种方法克服了包括多种抗原和解决癌细胞异质性的局限性.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
疫苗学疫苗学疫苗学

背景情况:

癌症免疫疗法已经取得了重大进展,癌症疫苗是关键技术.
抗原是癌症疫苗的关键组成部分,分为预定义或未识别的.
目前的疫苗经常使用预定义的抗原,但全瘤抗原疫苗提供了一个有希望的替代方案.

研究的目的:

审查使用全瘤抗原的癌症疫苗的最新进展.
专注于使用整个癌细胞或整个癌细胞溶解物作为抗原的疫苗.
突出整个瘤抗原疫苗在克服当前方法的局限性方面的潜力.

主要方法:

关于癌症疫苗的最新科学文献的审查.
基于整个癌细胞的癌症疫苗的分析.
专注于将整个水溶性细胞溶解物作为抗原的应用.

主要成果:

全癌细胞溶解物正在成为癌症疫苗的可行抗原.
具有全瘤抗原的疫苗可以包括广泛的抗原谱.
这些疫苗可以诱导针对广泛抗原的特异性T细胞,并解决癌细胞异质性的问题.

结论:

基于整个瘤抗原的癌症疫苗,特别是细胞溶解物,显示出显著的希望.
这种方法比传统的基于或mRNA的疫苗具有优势.
全瘤抗原疫苗代表了癌症免疫治疗中可行的和有前途的替代方案.

关键词:

癌症疫苗癌症疫苗免疫疗法免疫疗法新抗原是一种新抗原.瘤特定抗原的抗原.整个瘤都会被解体.

更多相关视频

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...